[go: up one dir, main page]

WO2013151407A1 - Method for extracting acorus calamus var. angustatus oil containing large amount of β-asarone using supercritical fluid extraction - Google Patents

Method for extracting acorus calamus var. angustatus oil containing large amount of β-asarone using supercritical fluid extraction Download PDF

Info

Publication number
WO2013151407A1
WO2013151407A1 PCT/KR2013/002932 KR2013002932W WO2013151407A1 WO 2013151407 A1 WO2013151407 A1 WO 2013151407A1 KR 2013002932 W KR2013002932 W KR 2013002932W WO 2013151407 A1 WO2013151407 A1 WO 2013151407A1
Authority
WO
WIPO (PCT)
Prior art keywords
extraction
iris
beta
solvent
sfe
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/KR2013/002932
Other languages
French (fr)
Korean (ko)
Inventor
이재의
김귀철
소수정
김희진
송하윤
조선호
김대현
조영익
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Jeonnam Bioindustry Foundation
Original Assignee
Jeonnam Bioindustry Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jeonnam Bioindustry Foundation filed Critical Jeonnam Bioindustry Foundation
Publication of WO2013151407A1 publication Critical patent/WO2013151407A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/02Pretreatment
    • C11B1/04Pretreatment of vegetable raw material
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/10Production of fats or fatty oils from raw materials by extracting
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00Production of fats or fatty oils from raw materials
    • C11B1/10Production of fats or fatty oils from raw materials by extracting
    • C11B1/104Production of fats or fatty oils from raw materials by extracting using super critical gases or vapours
    • CCHEMISTRY; METALLURGY
    • C11ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11BPRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B9/00Essential oils; Perfumes
    • C11B9/02Recovery or refining of essential oils from raw materials
    • C11B9/025Recovery by solvent extraction
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/54Improvements relating to the production of bulk chemicals using solvents, e.g. supercritical solvents or ionic liquids

Definitions

  • the present invention relates to a method for extracting iris root oil containing a large amount of beta asaron using a supercritical extraction method, more specifically, drying irises; Grinding the dried irises;
  • the method relates to a method for extracting an iris oil containing a large amount of beta asaron from an iris comprising extracting the iris powder by a supercritical extraction method using supercritical carbon dioxide and a cosolvent and concentrating the iris extract. .
  • Iris ( Acorus calamus var. Angustatus ) is a perennial herb that grows in wetlands and belongs to Tiannan province .
  • the habitat is known to extend from Jeju Island to the northern part of Korea. In Korea, it is customary to bathe or wash your hair in water boiled with iris leaves or iris roots on a single day in a three-day period to defeat bad energy.If you wash your hair in water boiled with iris leaves or iris roots, your hair will not fall out. She believed that she was shiny and smooth, and her hair would be long like a window stalk.
  • oriental medicine In oriental medicine, it has important effects such as sedation, palliative action, analgesic action, and antifungal action.
  • aromatic substance which is widely used as a fragrance for making lotion and high-quality perfume.
  • Asarone of 4-propenyl-1,2,5-trimethoxybenzene (C 12 H 16 O 3 , molecular weight 208.254 g / mol) is a major component of root, leaf and stem extracts of Acorus species.
  • Korean iris species which are native to Korea, are traditionally contained in large amounts of antibacterial components, and are known to exhibit antimicrobial and insecticidal effects such as treatment of hair dandruff and skin diseases (acne, athlete's foot, eczema, scabies, atopic bacteria, etc.) or food poisoning. Recently, it is used as a chemical sterilizer after steam treatment, and is known as a toxin, a morph modifier or an insect stimulant.
  • beta-aron As isomer of asaron, beta-aron ( ⁇ -asarone) is toxic while alpha-asarone ( ⁇ -asarone) has no toxicity and has only anti-freezing activity.
  • Asaron is known to be contained in a large amount of irises, among other plants, and irises are native to temperate regions and are aquatic plants native to any region including Jeju Island in Korea. Roots are beard roots, but long, long stems extend into the ground, and roots sprout from the bottom.
  • Essential oils contain 0.8 to 5% in the root stem and 0.1 to 0.3% in the leaves, and beta asaron is one of the essential oil components.
  • Pharmacological action is used as abortion, analgesic, aphrodisiac, fragrance, puncture, antiperspirant, tonic economy, antipyretic, hallucinogenic drug, homeopathic, sedative, stimulant, tonic or insect repellent.
  • Beta asaron extraction from conventional irises has been performed mostly through hot water extraction or methanol solvent extraction.
  • the conventional extraction method has a problem in that residual waste and organic solvent remain after extraction.
  • the extraction yield of beta asaron is low.
  • the inventors grind the irises to 0.5 mm to 1 mm particle size after natural drying and extract a large amount of beta from the irises by supercritical extraction using supercritical carbon dioxide and co-solvent. It was confirmed that the oil containing asaron can be extracted and completed the present invention.
  • Another object of the present invention is to provide an iris oil containing beta asaron extracted using the above extraction method.
  • the present invention comprises the steps of crushing the iris (step 1); Supercritical extraction of the iris powders using supercritical carbon dioxide and co-solvent at 40 ° C. to 60 ° C. and 200 bar to 400 bar pressure conditions (step 2); And it provides a method for extracting beta-aron containing iris oil comprising the step of concentrating the iris extract (step 3).
  • Step 1 is a pretreatment method for increasing the extraction yield of the irises, the crushed irises to a predetermined size.
  • the term "Iris” is used as a medicinal herb sprayed with perennial herbaceous plants belonging to Chunnamseong. It is known to have the effects of dry stomach, soothing, jingyeong, and leech, and is used for symptoms such as digestion, diarrhea, wet swelling, jeongan, vigilance, forgetfulness, mental anxiety, customs pain, seawater, bronchitis, carbuncle, and spear.
  • the root contains a fragrant substance that is used in the bath water.
  • the said iris uses the low temperature cold air drying dried iris.
  • cold air drying means a method of drying at low temperature.
  • the low temperature means a relatively low temperature, and generally the low temperature means a temperature range of 40 ° C to 60 ° C.
  • the low temperature cold wind drying in the present invention can be carried out for several days. It is preferably performed for 1 to 5 days, but may be appropriately adjusted according to the moisture content of the irises.
  • the grinding is preferably a pin mill or a low temperature mill, but is not limited thereto.
  • the diameter of the iris powder is preferably a size of 0.5 mm to 1 mm.
  • the particle size of the pulverized product is out of the range, there is a disadvantage in that the extraction efficiency of the iris is lowered.
  • the particle size of less than 0.5 mm the extraction efficiency is lowered due to the pressure load during supercritical extraction, the beta asaron contained in the particles difficult to extract to the outside by the supercritical fluid at the particle size of more than 2 mm have.
  • Step 2 is a step of supercritical extraction by adding a co-solvent to the supercritical carbon dioxide in order to extract the iris oil containing beta asaron from the iris.
  • the cosolvent is preferably ethanol, but is not limited thereto.
  • the cosolvent may use 1 to 10 vol% of the total supercritical fluid mixture, preferably 3 vol% of the total supercritical fluid mixture.
  • the supercritical extraction is preferably performed at a temperature of 40 °C to 60 °C, it is preferably carried out at 200 bar to 400 bar pressure conditions.
  • a high yield of iris oil supercritical extract of 6.2% was obtained under the extraction conditions of 50 °C and 200 bar, 40 °C and 300 It was confirmed that the iris supercritical fluid extract extracted by the addition of the co-solvent in the extraction condition of bar had a high content of beta asaron of 0.937 g.
  • Step 3 is a step of concentrating the iris supercritical extract to remove the cosolvent in the iris extract obtained by extraction.
  • the concentration can be carried out using conventional thickeners known in the art.
  • the present invention provides a iris oil containing a large amount of beta asaron derived from irises extracted by the above extraction method.
  • the method for extracting beta-asarone derived from irises according to the present invention includes supercritical extraction of crushed irises having a particle size of 0.5 mm to 1 mm by adding a co-solvent to a carbon dioxide supercritical fluid, thereby containing a large amount of beta-asarone from irises. It is effective to provide a method for extracting essential oils.
  • FIG. 1 shows the addition of 2 ml / min ethanol at 40 ° C. of a 0.5 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 200 bar supercritical extraction, and (c) Images show the iris extract after 300 bar supercritical extraction and (d) iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.
  • FIG. 2 shows the addition of 2 ml / min ethanol at 400 bar of a 2 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 50 ° C. supercritical extraction and (c) An image showing the iris powder after 60 ° C supercritical extraction and (d) 50 ° C supercritical extraction and (e) 60 ° C supercritical extraction.
  • Figure 3 is (a) before extraction, (b) after 200 bar supercritical extraction, (c) after 300 bar supercritical extraction at 50 ° C of 0.5 mm particle size iris powder according to an embodiment of the present invention and ( d) An image showing the iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.
  • FIG. 4 shows the addition of 2 ml / min ethanol at 50 ° C. of a 0.5 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 200 bar supercritical extraction, and (c) Images show the iris extract after 300 bar supercritical extraction and (d) iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.
  • Figure 5 (a) change in pressure, temperature change and extraction yield (%) change with or without cosolvent at 0.5 mm particle size according to an embodiment of the present invention, (b) temperature change at 200 bar pressure conditions And change in extraction yield (%) with and without cosolvent, (c) change in extraction yield (%) with temperature change at 300 bar pressure, and (d) temperature change and presence or absence of cosolvent at 400 bar pressure. It is a graph showing the change in extraction yield (%).
  • Figure 6 is a graph showing the results of HPLC quantification of (a) 7000 ppm, (b) 700 ppm and (c) 350 ppm for the beta asaron standard according to an embodiment of the present invention.
  • FIG. 7 is an image showing a calibration curve measurement result obtained to verify the results of HPLC quantitative analysis by concentration of the beta asaron standard according to an embodiment of the present invention.
  • FIG. 10 is a graph showing changes in total content of beta-aron and (b) change in total amount of beta-aron according to pressure change of (a) temperature change of an iris extract according to an embodiment of the present invention.
  • the irises inhabiting Hapyeongsan, Korea were naturally dried at 60 ° C. for 5 days and then pretreated by grinding to a size of 0.5 mm to 2 mm using a pin mill.
  • Supercritical extraction is controlled at temperatures of 40, 50 and 60 ° C., and the pressure is adjusted to 200, 300 and 400 bar at each temperature condition so that the amount of 100 g of the pretreated irises is extracted using a supercritical extraction device at each extraction condition. And supercritical extraction was performed for 100 minutes for each iris sample. In supercritical extraction, the flow rate was 60 ml / min (supercritical fluid extraction).
  • the irises inhabiting Hapyeongsan, Korea were dried at 60 ° C. for 5 days and then ground to a size of 0.5 mm using a grinder. 100 g of the prepared iris was put in 500 ml of a methanol solution, and the extract was supported for 24 hours at a temperature of 60 ° C., and then concentrated by using a vacuum concentrator to completely remove the solvent. Table 2 shows the extraction conditions.
  • the extraction yield of the iris extract obtained in the above Examples and Comparative Examples was measured.
  • 100 g (A) of the sample was put in the extraction basket, and the weight (B) of the extracted material obtained after the extraction was recorded.
  • Extraction yield measurement using cosolvent was carried out using supercritical carbon dioxide and cosolvent, supercritical extract material containing calamus oil was placed in a vacuum concentrator, and solvent was completely removed. 100 g (A ′) was recorded and calculated by the following equation.
  • Table 3 The results of Table 3 are shown in FIG. 5 according to temperature and pressure conditions. As shown in Figure 5, it can be seen that the extraction yield of the sample prepared in Example 4 (0.5 mm particle size, 50 °C temperature and 200 bar pressure conditions) was the highest, each pressure condition (200 bar, 300 bar And (b), (c) and (d) of Fig. 5 showing the extraction yield change according to 400 bar) to confirm that the sample using the co-solvent extraction yield (%) is higher than the sample without the co-solvent could.
  • HPLC analysis was performed using Waters HPLC with COSMOSIL 5C18MS-II, 250 mm ⁇ 4.6 mm (Nakala Teque, Inc., Japan) column at 10 ⁇ l injection volume and 0.1% formic acid (Fluka) as mobile phase. , USA) and acetonitrile (acetonitrile, JT Baker, USA) were eluted for 45 minutes at a flow rate of 1 ml / min using a concentration gradient (acetonitrile content: 20 wt% to 80 wt%).
  • the oven temperature was set at 35 ° C.
  • the components of the irises supercritical extracts of Examples 1 to 22 were examined through HPLC analysis, and the results are shown in FIG. 9. As shown in FIG. 9, the extraction yield of the iris extract extracted through Example 4 was 1.9 times higher than that of the methanol extract obtained from Comparative Example 1, and the beta asaron content of the iris extract extracted through Example 2 was obtained. It was confirmed that 1.9 times higher compared with the control Comparative Example 1.
  • the iris methanol extract extracted in Comparative Example 1 was used, to determine the concentration of beta asaron contained in iris oil, the sample by concentration using a beta asaron standard solution.
  • the chromatograms prepared and obtained through HPLC analysis are shown in FIG. 6.
  • the calibration curve for determination of concentration through the chromatogram obtained in FIG. 6 is shown in FIG. 7, and the conditions of the highest extraction yield and the high beta-asone content are shown in FIG. 8.
  • Example 4 50 °C, 200 bar and co-solvent use conditions
  • the conditions of Example 2 40 °C, 300 bar and co-solvent use) Conditions
  • Example 13 the extraction conditions were significantly higher in Example 4 conditions (50 °C, 200 bar and co-solvent use conditions) compared to Example 13 and the control Comparative Example 1 without the co-solvent
  • the conditions of Example 2 (40 ° C., 300 bar and cosolvent use conditions) were confirmed to be significantly higher in beta-asarone content in the iris oil than in Example 13 without the cosolvent and Comparative Example 1.
  • FIG. 10 Changes in the total content of beta-asarone according to the temperature and pressure conditions of the iris supercritical extract using 0.5 mm particle size except 19 to 22 of Examples 1 to 22 are shown in FIG. 10.
  • the highest beta-aronone content was obtained in the extraction conditions using 40 ° C., 300 bar, and the cosolvent prepared in Example 2, and the sample using the cosolvent at the same temperature was used as the cosolvent. It was confirmed that the total extraction content of beta asaron is higher than the sample not used.
  • Example 1 to 22 the beta-aronon HPLC measurement concentration and the concentrated sample content of Examples 6, 9, 13, 18, 19, 20, 21, and 22 having a pressure condition of 400 bar were measured. And FIG. 11. As shown in Table 5 and Figure 11, regardless of the extraction temperature and pressure change, when using the particle size of 0.5 mm, the extraction yield was up to 2.4 times higher than that of the particle size of 2 mm, beta asaron The content was also confirmed to be as high as the extraction yield.
  • Cheongpo extract obtained in Example 6 showed the highest content of beta asaron, it was confirmed that the amount of extraction decreases slightly with increasing temperature. In addition, it was confirmed that the extraction amount increases as the co-solvent is present and the particle size is small. Therefore, it can be seen that the particle size and the use of the co-solvent is an important factor.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Extraction Or Liquid Replacement (AREA)

Description

초임계 유체 추출법을 이용한 베타아사론이 다량 함유된 창포 오일 추출 방법Extraction method of iris oil containing a large amount of beta asaron using supercritical fluid extraction

본 발명은 초임계 추출법을 이용한 베타아사론이 다량 함유된 창포 뿌리 오일 추출 방법에 관한 것으로, 더 상세하게는 창포를 건조하는 단계; 상기 창포 건조물을 분쇄하는 단계; 상기 창포 분쇄물을 초임계 이산화탄소 및 보조용매를 사용한 초임계 추출법으로 추출하는 단계 및 상기 창포 추출물을 농축하는 단계를 포함하는 창포로부터 다량의 베타아사론을 포함하는 창포 오일을 추출하는 방법에 관한 것이다.The present invention relates to a method for extracting iris root oil containing a large amount of beta asaron using a supercritical extraction method, more specifically, drying irises; Grinding the dried irises; The method relates to a method for extracting an iris oil containing a large amount of beta asaron from an iris comprising extracting the iris powder by a supercritical extraction method using supercritical carbon dioxide and a cosolvent and concentrating the iris extract. .

창포(Acorus calamus var. angustatus)는 천남성과에 속하며 습지에서 자라는 다년생 수초로서, 최근 하천이나 수정원 등에 이용이 증가하고 있다. 자생지는 대한민국 제주도에서 북부지역까지인 것으로 알려져 있다. 대한민국에서는 세시풍속으로 단오 날에 창포 잎 또는 창포 뿌리를 삶은 물에 목욕하거나 머리를 감아 나쁜 기운을 물리친다는 풍습이 있으며, 상기 창포 잎 또는 창포 뿌리를 삶은 물에 머리를 감으면 머리가 빠지지 않고 윤기가 나며 매끄러운 머릿결을 유지하고 창호 줄기처럼 머리가 길어진다고 믿었다.Iris ( Acorus calamus var. Angustatus ) is a perennial herb that grows in wetlands and belongs to Tiannan Province . The habitat is known to extend from Jeju Island to the northern part of Korea. In Korea, it is customary to bathe or wash your hair in water boiled with iris leaves or iris roots on a single day in a three-day period to defeat bad energy.If you wash your hair in water boiled with iris leaves or iris roots, your hair will not fall out. She believed that she was shiny and smooth, and her hair would be long like a window stalk.

한방에서는 진정작용, 건위작용, 진통작용, 항진균작용 등의 효능이 있어 중요시되고 있으며, 종기, 구충제 등 민간요법으로도 많이 활용되고 있다. 또 방향성 물질이 있어 향료로서 화장수, 고급향수 제조 등에 많이 활용되고 있다.In oriental medicine, it has important effects such as sedation, palliative action, analgesic action, and antifungal action. In addition, there is an aromatic substance, which is widely used as a fragrance for making lotion and high-quality perfume.

또한, 대한민국 내 연구 결과 창포 정유가 구강 내 충치균인 Streptococous mutans 증식 억제 효과가 있으며(You, Y.S, Park, K.M and Kim, Y.B., Kor.J.Appl. Microbiol. Biotechnol, 21(2), 187-191 (1993)), 병아리 및 마우스의 자발운동 억제 효과(Park, J.H., Reserch review of Kyungpook Natl. Univ., 21(1) 637-642 (1978)) 및 항산화 효능(Hwang. M.S.,The theme of master of science in the Graduate of HEalth Sciences, Catholic Univ. of Daegu (2004))을 가지고 있다고 보고되었다. In addition, Korean studies have shown that iris oil has an inhibitory effect on the growth of Streptococous mutans , which is an oral cavity (You, YS, Park, KM and Kim, YB, Kor.J.Appl.Microbiol.Biotechnol, 21 (2), 187- 191 (1993)), the inhibitory effect of chicks and mice (Park, JH, Reserch review of Kyungpook Natl. Univ., 21 (1) 637-642 (1978)) and antioxidant efficacy (Hwang. MS, The theme of master of science in the Graduate of HEalth Sciences, Catholic Univ. of Daegu (2004).

4-propenyl-1,2,5-trimethoxybenzene(C12H16O3, 분자량 208.254 g/mol)의 아사론(asarone)은 창포 종(Acorus species)의 뿌리, 잎 및 줄기 추출물의 주요성분이다. 대한민국에서 자생하는 창포 종은 전통적으로 향균 성분이 다량 함유되어 있어, 머리 비듬균과 피부병의 치료(여드름, 무좀, 습진, 옴, 아토피성균 등) 또는 식중독예방 등의 항균 및 살충효과를 보인다고 알려져 있다. 최근에는 증기처리 후에 화학멸균제로 사용되며, 독소, 형태변형제 또는 곤충자극제 등으로 알려져 있다. Asarone of 4-propenyl-1,2,5-trimethoxybenzene (C 12 H 16 O 3 , molecular weight 208.254 g / mol) is a major component of root, leaf and stem extracts of Acorus species. Korean iris species, which are native to Korea, are traditionally contained in large amounts of antibacterial components, and are known to exhibit antimicrobial and insecticidal effects such as treatment of hair dandruff and skin diseases (acne, athlete's foot, eczema, scabies, atopic bacteria, etc.) or food poisoning. Recently, it is used as a chemical sterilizer after steam treatment, and is known as a toxin, a morph modifier or an insect stimulant.

한편, 아사론의 이성질체로서, 베타아사론(β-asarone)은 독성이 있는 반면 알파아사론(α-asarone)은 독성이 없고 항결빙 활성만을 지니고 있다. 아사론은 여러 식물 중 특히 창포에 다량 함유되어 있는 것으로 알려져 있으며, 창포는 온대지방이 원산지로서 대한민국에서도 제주도를 비롯한 어느 지역에서나 자생하는 수생식물이다. 뿌리는 수염 뿌리이지만, 땅 속으로 굵고 마디가 많은 땅속 줄기를 길게 뻗으며 그 밑 부분에서 뿌리가 돋는다. 정유가 뿌리줄기에 0.8 내지 5%, 잎에 0.1 내지 0.3% 함유되어 있으며, 정유 성분 중 대표적인 것이 베타아사론이다. 약리작용으로는 낙태약, 진통제, 최음제, 방향제, 구풍제, 발한제, 통경제, 해열제, 환각유발제, 동종요법제, 진정제, 흥분제, 강장제 또는 구충제 등으로 이용되고 있다. On the other hand, as isomer of asaron, beta-aron (β-asarone) is toxic while alpha-asarone (α-asarone) has no toxicity and has only anti-freezing activity. Asaron is known to be contained in a large amount of irises, among other plants, and irises are native to temperate regions and are aquatic plants native to any region including Jeju Island in Korea. Roots are beard roots, but long, long stems extend into the ground, and roots sprout from the bottom. Essential oils contain 0.8 to 5% in the root stem and 0.1 to 0.3% in the leaves, and beta asaron is one of the essential oil components. Pharmacological action is used as abortion, analgesic, aphrodisiac, fragrance, puncture, antiperspirant, tonic economy, antipyretic, hallucinogenic drug, homeopathic, sedative, stimulant, tonic or insect repellent.

종래 창포 유래의 베타아사론 추출은 대부분 열수추출법이나 메탄올 용매추출법을 통해 수행되어 왔다. 이와 같은, 종래 추출 방법은 추출 후 잔존 폐기물 및 유기용매가 잔류하는 문제점이 있다. 또한, 베타아사론의 추출 수율이 낮다는 단점이 있다. Beta asaron extraction from conventional irises has been performed mostly through hot water extraction or methanol solvent extraction. As described above, the conventional extraction method has a problem in that residual waste and organic solvent remain after extraction. In addition, there is a disadvantage that the extraction yield of beta asaron is low.

이러한 배경 하에서, 본 발명자들은 창포를 자연 건조 후 0.5 mm 내지 1 mm 입자 크기로 분쇄하여 초임계 이산화탄소(supercritical carbon dioxide) 및 보조용매(co-solvent)를 이용하여 초임계 추출함으로써 창포로부터 다량의 베타아사론을 함유하고 있는 오일을 추출할 수 있음을 확인하고 본 발명을 완성하였다. Under this background, the inventors grind the irises to 0.5 mm to 1 mm particle size after natural drying and extract a large amount of beta from the irises by supercritical extraction using supercritical carbon dioxide and co-solvent. It was confirmed that the oil containing asaron can be extracted and completed the present invention.

본 발명의 목적은 초임계 유체 추출을 이용한 창포 유래의 베타아사론을 함유하는 창포오일을 추출하는 방법을 제공하는 것이다.It is an object of the present invention to provide a method for extracting iris oil containing beta asaron derived from irises using supercritical fluid extraction.

본 발명의 다른 목적은 상기의 추출 방법을 이용하여 추출한 베타아사론을 함유하는 창포오일을 제공하는 것이다.Another object of the present invention is to provide an iris oil containing beta asaron extracted using the above extraction method.

상기 과제를 해결하기 위해, 본 발명은 창포를 분쇄하는 단계(단계 1); 상기 창포 분쇄물을 40℃ 내지 60℃ 온도 및 200 bar 내지 400 bar 압력 조건 하에서 초임계 이산화탄소(supercritical carbon dioxide) 및 보조용매(co-solvent)를 사용하여 초임계 추출하는 단계(단계 2); 및 상기 창포 추출물을 농축하는 단계(단계 3)을 포함하는 베타아사론이 함유된 창포오일의 추출 방법을 제공한다.In order to solve the above problems, the present invention comprises the steps of crushing the iris (step 1); Supercritical extraction of the iris powders using supercritical carbon dioxide and co-solvent at 40 ° C. to 60 ° C. and 200 bar to 400 bar pressure conditions (step 2); And it provides a method for extracting beta-aron containing iris oil comprising the step of concentrating the iris extract (step 3).

상기 단계 1은, 창포의 추출 수율을 증가시키기 위한 전처리 방법으로, 상기 창포를 일정 크기로 분쇄하는 단계이다.Step 1 is a pretreatment method for increasing the extraction yield of the irises, the crushed irises to a predetermined size.

본 발명에서 사용되는 용어 "창포"는, 천남성과에 속하는 다년생 초본식물로 뿌리는 한방에서 약재로 사용하고 있다. 건위, 진정, 진경, 거단 등의 효능이 있다고 알려져 있어, 소화물량, 설사, 습체비창, 전간, 경계, 건망, 정신불안, 풍습비통, 해수, 기관지염, 옹종, 개창 등의 증상에 사용되고 있다. 또한, 뿌리에는 방향성 물질이 함유되어 있어 목욕시 물에 넣어 사용되고 있다.As used in the present invention, the term "Iris" is used as a medicinal herb sprayed with perennial herbaceous plants belonging to Chunnamseong. It is known to have the effects of dry stomach, soothing, jingyeong, and leech, and is used for symptoms such as digestion, diarrhea, wet swelling, jeongan, vigilance, forgetfulness, mental anxiety, customs pain, seawater, bronchitis, carbuncle, and spear. In addition, the root contains a fragrant substance that is used in the bath water.

상기 창포는 저온 냉풍 건조 건조된 창포를 사용하는 것이 바람직하다. 본 발명에서 사용되는 용어 "저온 냉풍 건조"는, 저온에서 건조시키는 방법을 의미한다. 건조 공정에 있어서, 상기 저온이란 상대적으로 낮은 온도를 의미하는 것으로, 일반적으로 저온의 범위는 40℃ 내지 60℃의 온도 범위를 의미한다. 본 발명에서의 상기 저온 냉풍 건조는 수일 동안 수행될 수 있다. 1 내지 5일 동안 수행되는 것이 바람직하나, 창포의 수분 함량에 따라 적절히 조절될 수 있다.It is preferable that the said iris uses the low temperature cold air drying dried iris. As used herein, the term "cold cold air drying" means a method of drying at low temperature. In the drying process, the low temperature means a relatively low temperature, and generally the low temperature means a temperature range of 40 ° C to 60 ° C. The low temperature cold wind drying in the present invention can be carried out for several days. It is preferably performed for 1 to 5 days, but may be appropriately adjusted according to the moisture content of the irises.

상기 분쇄는 분쇄기를 사용하는 것이 바람직하고, 핀형분쇄기 또는 저온분쇄기인 것을 사용하는 것이 바람직하나, 이제 제한되는 것은 아니다.It is preferable to use a grinder, and the grinding is preferably a pin mill or a low temperature mill, but is not limited thereto.

또한, 상기 창포 분쇄물의 직경은 0.5 mm 내지 1 mm의 크기인 것이 바람직하다. 상기 분쇄물의 입자 크기가 상기 범위를 벗어날 경우 창포의 추출 효율이 떨어지는 단점이 있다. 특히, 0.5 mm 미만의 입자 크기에서는 초임계 추출 시 압력 부하로 인하여 추출 효율이 떨어지며, 2 mm 이상의 입자 크기에서는 입자 속에 포함되어 있는 베타아사론이 초임계 유체에 의해 외부로 추출되기 어려워지는 단점이 있다.In addition, the diameter of the iris powder is preferably a size of 0.5 mm to 1 mm. When the particle size of the pulverized product is out of the range, there is a disadvantage in that the extraction efficiency of the iris is lowered. In particular, the particle size of less than 0.5 mm, the extraction efficiency is lowered due to the pressure load during supercritical extraction, the beta asaron contained in the particles difficult to extract to the outside by the supercritical fluid at the particle size of more than 2 mm have.

상기 단계 2는, 창포에서 베타아사론을 함유하는 창포오일을 추출하기 위해 창포 분쇄물을 초임계 이산화탄소에 보조용매를 첨가하여 초임계 추출하는 단계이다.Step 2 is a step of supercritical extraction by adding a co-solvent to the supercritical carbon dioxide in order to extract the iris oil containing beta asaron from the iris.

상기 보조용매는 에탄올(ethanol)인 것이 바람직하나, 이에 제한되는 것은 아니다. 또한, 상기 보조용매는 전체 초임계 유체 혼합물 대비 1 내지 10 vol%를 사용할 수 있으며, 바람직하게는 전체 초임계 유체 혼합물 대비 3 vol%를 사용할 수 있다.The cosolvent is preferably ethanol, but is not limited thereto. In addition, the cosolvent may use 1 to 10 vol% of the total supercritical fluid mixture, preferably 3 vol% of the total supercritical fluid mixture.

또한, 상기 초임계 추출은 40℃ 내지 60℃ 온도에서 수행되는 것이 바람직하며, 200 bar 내지 400 bar 압력 조건에서 수행되는 것이 바람직하다.In addition, the supercritical extraction is preferably performed at a temperature of 40 ℃ to 60 ℃, it is preferably carried out at 200 bar to 400 bar pressure conditions.

이에 따라, 본 발명의 일 실시예로서 0.5 mm 입자 크기의 창포 분쇄물을 사용한 결과, 50℃ 및 200 bar의 추출조건에서 6.2%의 높은 수율의 창포 오일 초임계 추출물을 얻었으며, 40℃ 및 300 bar의 추출조건에서 보조용매를 첨가하여 추출한 창포 초임계 유체 추출물에서 0.937 g의 높은 베타아사론 함량을 갖음을 확인하였다.Accordingly, as a result of the use of 0.5 mm particle size iris powder as an embodiment of the present invention, a high yield of iris oil supercritical extract of 6.2% was obtained under the extraction conditions of 50 ℃ and 200 bar, 40 ℃ and 300 It was confirmed that the iris supercritical fluid extract extracted by the addition of the co-solvent in the extraction condition of bar had a high content of beta asaron of 0.937 g.

상기 단계 3은, 추출하여 얻은 창포 추출물 내 보조용매를 제거하기 위하여 상기 창포 초임계 추출물을 농축시키는 단계이다. 상기 농축은 당업계에 알려져 있는 통상의 농축기를 사용하여 수행할 수 있다.Step 3 is a step of concentrating the iris supercritical extract to remove the cosolvent in the iris extract obtained by extraction. The concentration can be carried out using conventional thickeners known in the art.

또한, 본 발명은 상기의 추출 방법으로 추출된 창포 유래의 베타아사론이 다량 함유된 창포오일을 제공한다.In addition, the present invention provides a iris oil containing a large amount of beta asaron derived from irises extracted by the above extraction method.

본 발명에 따른 창포 유래의 베타아사론 추출 방법은 0.5 mm 내지 1 mm 입자 크기로 분쇄된 창포를 이산화탄소 초임계 유체에 보조용매를 첨가하여 초임계 추출함으로써, 창포로부터 다량의 베타아사론이 포함된 에센셜 오일을 추출하는 방법을 제공하는 효과가 있다.The method for extracting beta-asarone derived from irises according to the present invention includes supercritical extraction of crushed irises having a particle size of 0.5 mm to 1 mm by adding a co-solvent to a carbon dioxide supercritical fluid, thereby containing a large amount of beta-asarone from irises. It is effective to provide a method for extracting essential oils.

도 1은, 본 발명의 일 실시예에 따른 0.5 mm 입자 크기 창포 분쇄물의 40℃에서의 2 ml/min 에탄올을 첨가한 (a) 추출 전, (b) 200 bar 초임계 추출 후, (c) 300 bar 초임계 추출 후 및 (d) 400 bar에서 추출 후의 창포 분말 및 (e) 200 bar 추출 후, (f) 300 bar 추출 후 및 (g) 400 bar 추출 후의 창포 추출액을 나타낸 이미지이다.FIG. 1 shows the addition of 2 ml / min ethanol at 40 ° C. of a 0.5 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 200 bar supercritical extraction, and (c) Images show the iris extract after 300 bar supercritical extraction and (d) iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.

도 2는, 본 발명의 일 실시예에 따른 2 mm 입자 크기 창포 분쇄물의 400 bar에서의 2 ml/min 에탄올을 첨가한 (a) 추출 전, (b) 50℃ 초임계 추출 후 및 (c) 60℃ 초임계 추출 후 창포 분말 및 (d) 50℃ 초임계 추출 후 및 (e) 60℃ 초임계 추출 후의 창포 추출액을 나타낸 이미지이다.FIG. 2 shows the addition of 2 ml / min ethanol at 400 bar of a 2 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 50 ° C. supercritical extraction and (c) An image showing the iris powder after 60 ° C supercritical extraction and (d) 50 ° C supercritical extraction and (e) 60 ° C supercritical extraction.

도 3은, 본 발명의 일 실시예에 따른 0.5 mm 입자 크기 창포 분쇄물의 50℃에서의 (a) 추출 전, (b) 200 bar 초임계 추출 후, (c) 300 bar 초임계 추출 후 및 (d) 400 bar에서 추출 후의 창포 분말 및 (e) 200 bar 추출 후, (f) 300 bar 추출 후 및 (g) 400 bar 추출 후의 창포 추출액을 나타낸 이미지이다.Figure 3 is (a) before extraction, (b) after 200 bar supercritical extraction, (c) after 300 bar supercritical extraction at 50 ° C of 0.5 mm particle size iris powder according to an embodiment of the present invention and ( d) An image showing the iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.

도 4는, 본 발명의 일 실시예에 따른 0.5 mm 입자 크기 창포 분쇄물의 50℃에서의 2 ml/min 에탄올을 첨가한 (a) 추출 전, (b) 200 bar 초임계 추출 후, (c) 300 bar 초임계 추출 후 및 (d) 400 bar에서 추출 후의 창포 분말 및 (e) 200 bar 추출 후, (f) 300 bar 추출 후 및 (g) 400 bar 추출 후의 창포 추출액을 나타낸 이미지이다.FIG. 4 shows the addition of 2 ml / min ethanol at 50 ° C. of a 0.5 mm particle size iris mill according to one embodiment of the invention before (a) extraction, (b) after 200 bar supercritical extraction, and (c) Images show the iris extract after 300 bar supercritical extraction and (d) iris powder after extraction at 400 bar and (e) 200 bar extraction, (f) 300 bar extraction and (g) 400 bar extraction.

도 5는, 본 발명의 일 실시예에 따른 0.5 mm 입자 크기에서의 (a) 압력 변화, 온도 변화 및 보조용매 사용 유무에 따른 추출 수율(%) 변화, (b) 200 bar 압력 조건에서 온도 변화 및 보조용매 사용 유무에 따른 추출 수율(%) 변화, (c) 300 bar 압력 조건에서 온도 변화에 따른 추출 수율(%) 변화 및 (d) 400 bar 압력 조건에서 온도 변화 및 보조용매 사용 유무에 따른 추출 수율(%) 변화를 나타낸 그래프이다.Figure 5, (a) change in pressure, temperature change and extraction yield (%) change with or without cosolvent at 0.5 mm particle size according to an embodiment of the present invention, (b) temperature change at 200 bar pressure conditions And change in extraction yield (%) with and without cosolvent, (c) change in extraction yield (%) with temperature change at 300 bar pressure, and (d) temperature change and presence or absence of cosolvent at 400 bar pressure. It is a graph showing the change in extraction yield (%).

도 6은, 본 발명의 일 실시예에 따른 베타아사론의 표준물질에 대한 (a) 7000 ppm, (b) 700 ppm 및 (c) 350 ppm의 HPLC 정량 결과를 나타낸 그래프이다.Figure 6 is a graph showing the results of HPLC quantification of (a) 7000 ppm, (b) 700 ppm and (c) 350 ppm for the beta asaron standard according to an embodiment of the present invention.

도 7은, 본 발명의 일 실시예에 따른 베타아사론의 표준물질의 농도별 HPLC 정량분석 결과를 검증하기 위해 얻은 검량선 측정 결과를 나타낸 이미지이다. 7 is an image showing a calibration curve measurement result obtained to verify the results of HPLC quantitative analysis by concentration of the beta asaron standard according to an embodiment of the present invention.

도 8은, 본 발명의 일 실시예에 따른 (a) 50℃ 및 200 bar 압력 조건하에서 보조용매를 사용한 추출 오일 및 (b) 40℃ 및 300 bar 압력 조건하에서 보조용매를 사용한 추출 오일의 HPLC 결과를 나타낸 그래프이다.8 shows HPLC results of (a) extraction oil using co-solvent under 50 ° C. and 200 bar pressure conditions and (b) extraction oil using co-solvent under 40 ° C. and 300 bar pressure conditions according to an embodiment of the present invention. Is a graph.

도 9는, 본 발명의 일 실시예에 따른 추출 수율이 높은 실시예 4와 실시예 13 및 대조구 비교예 1의 (a) 추출 수율 변화; 및 베타아사론 함량이 높은 실시예 2와 실시예 13 및 대조구 비교예 1의 (b) 추출 조건에 따른 창포 오일 속에 함유된 베타아사론 총 함량 변화를 나타낸 그래프이다.9 is (a) extraction yield change of Example 4 and Example 13 and Comparative Example 1 of the high extraction yield according to an embodiment of the present invention; And (b) (b) extraction of beta-asarone total content in the iris oil according to the extraction conditions of Example 2, Example 13, and Comparative Example 1 of the high beta-aron content.

도 10은, 본 발명의 일 실시예에 따른 창포 추출물의 (a) 온도 변화에 따른 베타아사론 총 함량 변화 및 (b) 압력 변화에 따른 베타아사론 총 함량 변화를 나타낸 그래프이다. 10 is a graph showing changes in total content of beta-aron and (b) change in total amount of beta-aron according to pressure change of (a) temperature change of an iris extract according to an embodiment of the present invention.

도 11은, 본 발명의 일 실시예에 따른 창포 초임계 추출물의 400 bar 압력 조건에서의 입자 크기 및 온도 변화에 따른 (a) 베타아사론 총 함량 변화 및 (b) 추출 수율(%) 변화를 나타낸 그래프이다.Figure 11, (a) the total content of the beta asaron and (b) the extraction yield (%) change according to the particle size and temperature change at 400 bar pressure condition of the iris supercritical extract according to an embodiment of the present invention The graph shown.

이하, 실시예를 통해 본 발명을 보다 상세히 설명한다. 그러나 하기의 실시예는 오로지 본 발명을 설명하기 위한 것으로 이들 실시예에 의해 본 발명의 범위가 한정되는 것은 아니다. Hereinafter, the present invention will be described in more detail with reference to Examples. However, the following examples are only for illustrating the present invention and the scope of the present invention is not limited by these examples.

실시예 1 내지 22: 창포 초임계 추출Examples 1 to 22: Iris supercritical extraction

대한민국 함평산에 서식하는 창포를 60℃에서 5일 동안 자연 건조한 후 핀형분쇄기를 이용하여 0.5 mm 내지 2 mm의 크기로 분쇄하여 전처리하였다. 초임계 추출은 40, 50 및 60℃ 온도로 조절하고, 각 온도 조건에서 압력을 200, 300 및 400 bar로 조절하여 각 추출 조건에서 초임계 추출 장치를 이용하여 상기 전처리된 창포를 100 g의 양으로 주입하고 각 창포 시료당 100분 동안 초임계 추출을 실시하였다. 초임계 추출 시 유량은 60 ml/min으로 하였다(SFE(supercritical fluid extraction) 추출법). 또한, 초임계 이산화탄소 및 보조용매를 함께 사용하여 추출할 경우, 초기 해당 압력 유지 후, 1분 동안 순수 초임계 이산화탄소로 추출하고 60분 동안 2 ml/min의 에탄올(주정)을 사용하여 추출한 후 39분 동안 순수 초임계 이산화탄소로 추출을 실시하였다(SFE with co-solvent). 초임계 추출이 완료되면, 초임계 추출 장치의 추출조 압력을 낮추어 초임계유체 상태를 해제하여 추출물을 회수하고 농축기를 이용하여 농축하였다. 하기 표 1에 상세한 추출 조건을 나타내었으며, 도 1 내지 도 4에 창포 분말 및 창포 추출액의 이미지를 나타내었다.The irises inhabiting Hapyeongsan, Korea were naturally dried at 60 ° C. for 5 days and then pretreated by grinding to a size of 0.5 mm to 2 mm using a pin mill. Supercritical extraction is controlled at temperatures of 40, 50 and 60 ° C., and the pressure is adjusted to 200, 300 and 400 bar at each temperature condition so that the amount of 100 g of the pretreated irises is extracted using a supercritical extraction device at each extraction condition. And supercritical extraction was performed for 100 minutes for each iris sample. In supercritical extraction, the flow rate was 60 ml / min (supercritical fluid extraction). In addition, when extracted using a combination of supercritical carbon dioxide and co-solvent, after maintaining the initial pressure, extracted with pure supercritical carbon dioxide for 1 minute and extracted with 2 ml / min ethanol (alcohol) for 60 minutes 39 Extraction was performed with pure supercritical carbon dioxide for minutes (SFE with co-solvent). When the supercritical extraction was completed, the pressure of the extraction tank of the supercritical extraction device was lowered to release the supercritical fluid state, and the extract was recovered and concentrated using a concentrator. Detailed extraction conditions are shown in Table 1 below, and images of iris powder and iris extract are shown in FIGS. 1 to 4.

표 1 실시예 번호 추출조건 추출온도 (℃) 추출압력 (bar) 추출시간 (min) co--solvent 조건 입자크기(mm) 1 SFE with co-solvent 40 200 100 2 ml/min, 60 min 0.5 2 SFE with co-solvent 40 300 100 2 ml/min, 60 min 0.5 3 SFE with co-solvent 40 400 100 2 ml/min, 60 min 0.5 4 SFE with co-solvent 50 200 100 2 ml/min, 60 min 0.5 5 SFE with co-solvent 50 300 100 2 ml/min, 60 min 0.5 6 SFE with co-solvent 50 400 100 2 ml/min, 60 min 0.5 7 SFE with co-solvent 60 200 100 2 ml/min, 60 min 0.5 8 SFE with co-solvent 60 300 100 2 ml/min, 60 min 0.5 9 SFE with co-solvent 60 400 100 2 ml/min, 60 min 0.5 10 SFE 40 200 100 - 0.5 11 SFE 40 300 100 - 0.5 12 SFE 40 400 100 - 0.5 13 SFE 50 200 100 - 0.5 14 SFE 50 300 100 - 0.5 15 SFE 50 400 100 - 0.5 16 SFE 60 200 100 - 0.5 17 SFE 60 300 100 - 0.5 18 SFE 60 400 100 - 0.5 19 SFE with co-solvent 50 400 100 2 ml/min, 60 min 2 20 SFE with co-solvent 60 400 100 2 ml/min, 60 min 2 21 SFE 50 400 100 - 2 22 SFE 60 400 100 - 2 Table 1 Example number Extraction condition Extraction temperature (℃) Extraction pressure (bar) Extraction time (min) co--solvent condition Particle size (mm) One SFE with co-solvent 40 200 100 2 ml / min, 60 min 0.5 2 SFE with co-solvent 40 300 100 2 ml / min, 60 min 0.5 3 SFE with co-solvent 40 400 100 2 ml / min, 60 min 0.5 4 SFE with co-solvent 50 200 100 2 ml / min, 60 min 0.5 5 SFE with co-solvent 50 300 100 2 ml / min, 60 min 0.5 6 SFE with co-solvent 50 400 100 2 ml / min, 60 min 0.5 7 SFE with co-solvent 60 200 100 2 ml / min, 60 min 0.5 8 SFE with co-solvent 60 300 100 2 ml / min, 60 min 0.5 9 SFE with co-solvent 60 400 100 2 ml / min, 60 min 0.5 10 SFE 40 200 100 - 0.5 11 SFE 40 300 100 - 0.5 12 SFE 40 400 100 - 0.5 13 SFE 50 200 100 - 0.5 14 SFE 50 300 100 - 0.5 15 SFE 50 400 100 - 0.5 16 SFE 60 200 100 - 0.5 17 SFE 60 300 100 - 0.5 18 SFE 60 400 100 - 0.5 19 SFE with co-solvent 50 400 100 2 ml / min, 60 min 2 20 SFE with co-solvent 60 400 100 2 ml / min, 60 min 2 21 SFE 50 400 100 - 2 22 SFE 60 400 100 - 2

비교예 1: 창포 메탄올 추출Comparative Example 1: Iris methanol extraction

대한민국 함평산에 서식하는 창포를 60℃에서 5일 동안 건조한 후 분쇄기를 이용하여 0.5 mm의 크기로 분쇄하여 준비하였다. 준비된 창포 100 g을 메탄올(methanol) 용액 500 ml에 넣고 60℃로 온도하에서 24시간 동안 담지 추출한 후, 진공농축기를 사용하여 용매가 완전히 제거되도록 농축하여 준비하였다. 하기 표 2에 추출 조건을 나타내었다.The irises inhabiting Hapyeongsan, Korea were dried at 60 ° C. for 5 days and then ground to a size of 0.5 mm using a grinder. 100 g of the prepared iris was put in 500 ml of a methanol solution, and the extract was supported for 24 hours at a temperature of 60 ° C., and then concentrated by using a vacuum concentrator to completely remove the solvent. Table 2 shows the extraction conditions.

표 2 비교예번호 추출 조건 추출온도 (℃) 추출시간 (hr) 1 메탄올 추출 60 24 TABLE 2 Comparative Example Number Extraction conditions Extraction temperature (℃) Extraction time (hr) One Methanol extraction 60 24

실험예 1: 온도 및 압력 추출 조건에 따른 추출 수율 측정Experimental Example 1: Measurement of extraction yield according to temperature and pressure extraction conditions

상기 실시예 및 비교예에서 얻어진 창포 추출물의 추출 수율을 측정하였다. 초임계 유체 추출 수율 측정은 보조용매를 사용하지 않은 경우에는 시료 100 g(A)를 추출용 바스켓에 넣고 추출을 실시한 후 얻은 추출 물질의 중량(B)를 기록하였으며, 하기 식으로 계산하였다.The extraction yield of the iris extract obtained in the above Examples and Comparative Examples was measured. When the supercritical fluid extraction yield was measured, when the co-solvent was not used, 100 g (A) of the sample was put in the extraction basket, and the weight (B) of the extracted material obtained after the extraction was recorded.

추출수율(%)=(B/A)*100Extraction Yield (%) = (B / A) * 100

보조용매를 사용한 경우의 추출 수율 측정은 초임계 이산화탄소 및 보조용매를 사용하여 창포오일이 포함된 초임계 추출 물질을 진공농축기에 넣고 용매를 완전히 제거하고 얻은 추출 시료 중량(B') 및 창포 분말 시료 100g(A')를 기록하였으며, 하기 식으로 계산하였다. Extraction yield measurement using cosolvent was carried out using supercritical carbon dioxide and cosolvent, supercritical extract material containing calamus oil was placed in a vacuum concentrator, and solvent was completely removed. 100 g (A ′) was recorded and calculated by the following equation.

추출수율(%)=(B'/A')*100Extraction Yield (%) = (B '/ A') * 100

상기의 방법으로 얻어진 추출 수율 결과를 하기 표 3에 나타내었다. 표 3에 나타난 바와 같이, 40 내지 50℃ 온도 조건에서의 수율이 크게 변화하는 것을 확인할 수 있었다. 따라서, 온도 및 압력, 보조용매의 사용이 베타아사론이 함유된 창포오일의 추출 수율 및 베타아사론의 함량에 크게 영향을 주는 것을 확인할 수 있었으며, 온도 및 압력, 보조용매의 사용이 주요 영향 인자임을 알 수 있었다.The extraction yield obtained by the above method is shown in Table 3 below. As shown in Table 3, it was confirmed that the yield in the 40 to 50 ℃ temperature condition changes significantly. Therefore, it was confirmed that the temperature and pressure, the use of the co-solvent has a significant effect on the extraction yield and the content of the beta-saron of beta-aron containing beta-aron, the main influence factors I could see that.

표 3 실시예번호 추출조건 추출수율 (%) 1 SFE with co-solvent 5.565 2 SFE with co-solvent 5.527 3 SFE with co-solvent 5.684 4 SFE with co-solvent 6.220 5 SFE with co-solvent 5.713 6 SFE with co-solvent 5.765 7 SFE with co-solvent 5.214 8 SFE with co-solvent 5.531 9 SFE with co-solvent 5.540 10 SFE 3.682 11 SFE 4.296 12 SFE 4.321 13 SFE 4.388 14 SFE 3.881 15 SFE 4.073 16 SFE 4.348 17 SFE 4.437 18 SFE 4.088 19 SFE with co-solvent 3.400 20 SFE with co-solvent 4.317 21 SFE 2.376 22 SFE 3.914 비교예 1 methanol 3.253 TABLE 3 Example Number Extraction condition Extraction yield (%) One SFE with co-solvent 5.565 2 SFE with co-solvent 5.527 3 SFE with co-solvent 5.684 4 SFE with co-solvent 6.220 5 SFE with co-solvent 5.713 6 SFE with co-solvent 5.765 7 SFE with co-solvent 5.214 8 SFE with co-solvent 5.531 9 SFE with co-solvent 5.540 10 SFE 3.682 11 SFE 4.296 12 SFE 4.321 13 SFE 4.388 14 SFE 3.881 15 SFE 4.073 16 SFE 4.348 17 SFE 4.437 18 SFE 4.088 19 SFE with co-solvent 3.400 20 SFE with co-solvent 4.317 21 SFE 2.376 22 SFE 3.914 Comparative Example 1 methanol 3.253

상기 표 3의 결과를 도 5에 온도 조건 및 압력 조건에 따라 나타내었다. 도 5에 나타난 바와 같이, 상기 실시예 4(0.5 mm 입자크기, 50℃ 온도 및 200 bar 압력 조건)에서 제조된 시료의 추출 수율이 가장 높음을 알 수 있었으며, 각 압력 조건(200 bar, 300 bar 및 400 bar)에 따른 추출 수율 변화를 나타낸 도 5의 (b), (c) 및 (d)를 통해 보조용매를 사용한 시료가 보조용매를 사용하지 않은 시료보다 추출 수율(%)이 높음을 확인할 수 있었다.The results of Table 3 are shown in FIG. 5 according to temperature and pressure conditions. As shown in Figure 5, it can be seen that the extraction yield of the sample prepared in Example 4 (0.5 mm particle size, 50 ℃ temperature and 200 bar pressure conditions) was the highest, each pressure condition (200 bar, 300 bar And (b), (c) and (d) of Fig. 5 showing the extraction yield change according to 400 bar) to confirm that the sample using the co-solvent extraction yield (%) is higher than the sample without the co-solvent Could.

또한, 시료 입자 크기가 0.5 mm로 동일한 초임계 유체 추출 결과에서 50℃ 온도 및 200 bar 압력 조건에서 가장 높은 창포오일 추출 수율을 얻었으며, 동일한 압력 조건에서는 40℃에서 50℃로 온도를 증가시키는 구간에서는 추출 수율이 증가한 반면 60℃에서는 오히려 수율이 감소하는 결과를 보였다. 이는, 초임계 이산화탄소의 밀도 및 추출되는 창포 오일의 밀도가 연관성이 있음을 예측할 수 있는 결과이다. 특히, 초임계 이산화탄소를 단독으로 사용한 추출 조건보다 보조용매를 사용하여 추출한 조건에서 최대 2배 가까운 높은 추출 수율을 보임을 확인할 수 있었다.In addition, in the supercritical fluid extraction results with the sample particle size of 0.5 mm, the highest yield of iris oil extraction was obtained at 50 ° C and 200 bar pressure, and the temperature was increased from 40 ° C to 50 ° C at the same pressure condition. The extraction yield increased at, whereas the yield decreased at 60 ℃. This is a predictable result of the correlation between the density of supercritical carbon dioxide and the density of the extracted iris oil. In particular, it was confirmed that the extraction yield was up to 2 times higher in the extraction conditions using the co-solvent than the extraction conditions using the supercritical carbon dioxide alone.

실험예 2: 창포 초임계 추출물 성분 측정Experimental Example 2: Measurement of the iris supercritical extract component

HPLC 분석은 10 ㎕ 주입부피로, COSMOSIL 5C18MS-II, 250 mm×4.6 mm(Nakala Teque, Inc., Japan) 컬럼을 구비한 Waters HPLC를 이용하여 측정하였으며, 이동상으로 0.1% 포름산(formic acid, Fluka, USA) 및 아세토니트릴(acetonitrile, J.T. Baker, USA)의 혼합용매를 농도구배적으로(아세토니트릴 함량: 20 wt% 내지 80 wt%) 사용하여 1 ml/min의 유속으로 45분 동안 용출시켰다. 오븐의 온도는 35℃로 맞추었으며, 검출기로서 PDA(Waters 2998, UV: 190 nm 내지 800 nm, Waters, USA)를 사용하여 용출된 물질을 검출하였다. 표준물질로 시그마사(Sigma Chemical Co., St Louis, MO)로부터 구입한 베타아사론을 사용하였다.HPLC analysis was performed using Waters HPLC with COSMOSIL 5C18MS-II, 250 mm × 4.6 mm (Nakala Teque, Inc., Japan) column at 10 μl injection volume and 0.1% formic acid (Fluka) as mobile phase. , USA) and acetonitrile (acetonitrile, JT Baker, USA) were eluted for 45 minutes at a flow rate of 1 ml / min using a concentration gradient (acetonitrile content: 20 wt% to 80 wt%). The oven temperature was set at 35 ° C. and the eluted material was detected using a PDA (Waters 2998, UV: 190 nm to 800 nm, Waters, USA) as a detector. Beta asaron purchased from Sigma Chemical Co., St Louis, MO was used as a standard.

1) 창포 초임계 추출물 및 표준물질의 성분 비교 측정1) Comparative measurement of components of irises supercritical extract and standard substances

상기 실시예 1 내지 22의 창포 초임계 추출물에 대하여 HPLC 분석을 통해 성분을 조사하였으며, 결과를 도 9에 나타내었다. 도 9에 나타난 바와 같이, 상기 실시예 4를 통해 추출한 창포 추출물의 추출 수율이 대조구 비교예 1에서 얻은 메탄올 추출물과 비교하여 1.9배 높았으며, 상기 실시예 2를 통해 추출한 창포 추출물의 베타아사론 함량은 대조구 비교예 1과 비교하여 1.9배 높은 것을 확인할 수 있었다. The components of the irises supercritical extracts of Examples 1 to 22 were examined through HPLC analysis, and the results are shown in FIG. 9. As shown in FIG. 9, the extraction yield of the iris extract extracted through Example 4 was 1.9 times higher than that of the methanol extract obtained from Comparative Example 1, and the beta asaron content of the iris extract extracted through Example 2 was obtained. It was confirmed that 1.9 times higher compared with the control Comparative Example 1.

또한, 베타아사론 함량 비교를 위한 대조구로써 비교예 1에서 추출된 창포 메탄올 추출물을 사용하였으며, 창포오일 속에 포함된 베타아사론의 농도를 결정하기 위해 베타아사론 표준용액을 이용하여 농도별 시료를 제조하고 HPLC 분석을 통해 얻은 크로마토그램을 도 6에 나타내었다. 상기 도 6에서 얻은 크로마토그램을 통해 농도 결정을 위한 검량선을 도 7에 나타내었으며, 추출 수율이 가장 높은 조건 및 베타아사론 함량이 높은 조건을 도 8에 나타내었다. 도 8에 나타난 바와 같이, 상기 실시예 4의 조건(50℃, 200 bar 및 보조용매 사용 조건)에서 가장 높은 추출 수율을 얻었으며, 상기 실시예 2의 조건(40℃, 300 bar 및 보조용매 사용 조건)에서 창포 오일속에 함유된 베타아사론 농도가 가장 높은 것을 확인할 수 있었다. 또한 도 9에 나타난 바와 같이, 상기 실시예 4의 조건(50℃, 200 bar 및 보조용매 사용 조건)이 보조용매가 없는 실시예 13과 대조구 비교예 1과 비교하여 추출 수율이 확연히 높았으며, 상기 실시예 2의 조건(40℃, 300 bar 및 보조용매 사용 조건)이 보조용매가 없는 실시예 13과 대조구 비교예 1과 비교하여 창포 오일속에 함유된 베타아사론 함량이 확연히 높음을 확인할 수 있었다.In addition, as a control for comparing the content of beta asaron content, the iris methanol extract extracted in Comparative Example 1 was used, to determine the concentration of beta asaron contained in iris oil, the sample by concentration using a beta asaron standard solution. The chromatograms prepared and obtained through HPLC analysis are shown in FIG. 6. The calibration curve for determination of concentration through the chromatogram obtained in FIG. 6 is shown in FIG. 7, and the conditions of the highest extraction yield and the high beta-asone content are shown in FIG. 8. As shown in Figure 8, the highest extraction yield was obtained under the conditions of Example 4 (50 ℃, 200 bar and co-solvent use conditions), the conditions of Example 2 (40 ℃, 300 bar and co-solvent use) Conditions) was found to be the highest concentration of beta-aron in the iris oil. In addition, as shown in Figure 9, the extraction conditions were significantly higher in Example 4 conditions (50 ℃, 200 bar and co-solvent use conditions) compared to Example 13 and the control Comparative Example 1 without the co-solvent, The conditions of Example 2 (40 ° C., 300 bar and cosolvent use conditions) were confirmed to be significantly higher in beta-asarone content in the iris oil than in Example 13 without the cosolvent and Comparative Example 1.

2) 창포 초임계 추출물의 베타아사론 함량 측정2) Determination of Beta-Asaron Content of Iris Extract

상기 실시예 1 내지 22에서 얻어진 창포 초임계 추출물에 대하여 HPLC 분석을 수행하여 각 추출물 중에 함유되어 있는 베타아사론의 함량을 측정하였다. 한편, 베타아사론 함량 비료를 위하여 대조구로써 비교예 1에서 추출된 창포 메탄올 추출물을 사용하였으며, 결과를 표 4에 나타내었다. 표 4에 나타난 바와 같이, 상기 실시예 2에서 얻어진 창포 추출물 중의 베타아사론 함량이 가장 높음을 확인할 수 있었다.HPLC analysis was performed on the irises supercritical extracts obtained in Examples 1 to 22 to determine the content of beta asaron contained in each extract. On the other hand, the iris methanol extract extracted in Comparative Example 1 was used as a control for the beta asarone content fertilizer, the results are shown in Table 4. As shown in Table 4, it was confirmed that the beta-asarone content of the iris extract obtained in Example 2 was the highest.

표 4 실시예번호 베타아사론 함량 (ppm) 추출 오일에 함유된 총 베타아사론 함량 (g) 1 631.321 0.703 2 847.517 0.937 3 592.073 0.389 4 663.120 0.825 5 650.636 0.743 6 622.146 0.717 7 585.448 0.611 8 617.495 0.683 9 651.493 0.722 10 726.000 0.535 11 684.073 0.588 12 633.367 0.547 13 592.244 0.520 14 691.393 0.537 15 667.558 0.544 16 768.869 0.669 17 589.138 0.523 18 773.870 0.633 19 564.918 0.269 20 560.337 0.339 21 763.327 0.254 22 725.935 0.398 비교예 1 743.060 0.483 Table 4 Example Number Beta Asaron Content (ppm) Total Beta-Asarone Content in Extracted Oil (g) One 631.321 0.703 2 847.517 0.937 3 592.073 0.389 4 663.120 0.825 5 650.636 0.743 6 622.146 0.717 7 585.448 0.611 8 617.495 0.683 9 651.493 0.722 10 726.000 0.535 11 684.073 0.588 12 633.367 0.547 13 592.244 0.520 14 691.393 0.537 15 667.558 0.544 16 768.869 0.669 17 589.138 0.523 18 773.870 0.633 19 564.918 0.269 20 560.337 0.339 21 763.327 0.254 22 725.935 0.398 Comparative Example 1 743.060 0.483

상기 실시예 1 내지 22번 중 19 내지 22번을 제외한 0.5 mm 입자 크기를 이용한 창포 초임계 추출물의 온도 조건 및 압력 조건에 따른 베타아사론 총 함량 변화를 도 10에 나타내었다. 도 10에 나타난 바와 같이, 상기 실시예 2에서 제조된 40℃, 300 bar 및 보조용매를 사용한 추출 조건에서 가장 높은 베타아사론 함량을 나타내었으며, 동일한 온도 조건에서 보조용매를 사용한 시료가 보조용매를 사용하지 않은 시료보다 베타아사론의 추출 총 함량이 높음을 확인할 수 있었다.Changes in the total content of beta-asarone according to the temperature and pressure conditions of the iris supercritical extract using 0.5 mm particle size except 19 to 22 of Examples 1 to 22 are shown in FIG. 10. As shown in FIG. 10, the highest beta-aronone content was obtained in the extraction conditions using 40 ° C., 300 bar, and the cosolvent prepared in Example 2, and the sample using the cosolvent at the same temperature was used as the cosolvent. It was confirmed that the total extraction content of beta asaron is higher than the sample not used.

3) 시료 입자 크기에 따른 400 bar 압력 조건 하의 창포 초임계 추출물의 성분 분석3) Component analysis of Iris supercritical extract under 400 bar pressure according to sample particle size

상기 실시예 1 내지 22에서 압력 조건이 400 bar인 실시예 6, 9, 13, 18, 19, 20, 21 및 22의 베타아사론 HPLC 측정 농도 및 농축된 시료 함량을 측정하였으며, 결과를 표 5 및 도 11에 나타내었다. 표 5 및 도 11에 나타난 바와 같이, 추출 온도 및 압력 변화에 무관하게 입자 크기를 0.5 mm로 사용하는 경우에 입자 크기를 2 mm로 하는 경우보다 최대 2.4배 이상 추출 수율이 높았으며, 베타아사론 함량 역시 추출 수율 만큼 높은 것을 확인할 수 있었다.In Examples 1 to 22, the beta-aronon HPLC measurement concentration and the concentrated sample content of Examples 6, 9, 13, 18, 19, 20, 21, and 22 having a pressure condition of 400 bar were measured. And FIG. 11. As shown in Table 5 and Figure 11, regardless of the extraction temperature and pressure change, when using the particle size of 0.5 mm, the extraction yield was up to 2.4 times higher than that of the particle size of 2 mm, beta asaron The content was also confirmed to be as high as the extraction yield.

상기 실시예 6에서 얻어진 청포 추출물에서 가장 높은 베타아사론의 함량을 보였으며, 온도가 증가할수록 추출양은 다소 감소하는 것을 확인할 수 있었다. 또한, 보조용매가 존재하고 입자크기가 작을수록 추출양이 증가하는 것을 확인할 수 있었다. 따라서, 입자크기 및 보조용매의 사용이 중요한 영향을 미치는 인자임을 알 수 있다.Cheongpo extract obtained in Example 6 showed the highest content of beta asaron, it was confirmed that the amount of extraction decreases slightly with increasing temperature. In addition, it was confirmed that the extraction amount increases as the co-solvent is present and the particle size is small. Therefore, it can be seen that the particle size and the use of the co-solvent is an important factor.

표 5 실시예 번호 조건 온도 (℃) 압력 (bar) 베타아사론 측정 농도(ppm) 농축된 베타아사론 총 함량 (g) 농축된 시료 함량 (%) 6 SFE+co-solvent (0.5 mm) 50 400 622.146 0.717 5.765 19 SFE+co-solvent (2 mm) 50 400 564.918 0.269 2.38 13 SFE (0.5 mm) 50 400 667.558 0.520 4.073 21 SFE (2 mm) 50 400 763.327 0.254 1.663 9 SFE+co-solvent (0.5 mm) 60 400 651.493 0.722 5.54 20 SFE+co-solvent (2 mm) 60 400 560.337 0.339 3.022 18 SFE (0.5 mm) 60 400 773.870 0.633 4.088 22 SFE (2 mm) 60 400 725.935 0.398 2.74 Table 5 Example number Condition Temperature (℃) Pressure (bar) Beta asarone measurement concentration (ppm) Concentrated Beta Asaron Content (g) Concentrated Sample Content (%) 6 SFE + co-solvent (0.5 mm) 50 400 622.146 0.717 5.765 19 SFE + co-solvent (2 mm) 50 400 564.918 0.269 2.38 13 SFE (0.5 mm) 50 400 667.558 0.520 4.073 21 SFE (2 mm) 50 400 763.327 0.254 1.663 9 SFE + co-solvent (0.5 mm) 60 400 651.493 0.722 5.54 20 SFE + co-solvent (2 mm) 60 400 560.337 0.339 3.022 18 SFE (0.5 mm) 60 400 773.870 0.633 4.088 22 SFE (2 mm) 60 400 725.935 0.398 2.74

Claims (5)

창포를 분쇄하는 단계;Crushing irises; 상기 창포 분쇄물을 40℃ 내지 60℃ 온도 및 200 bar 내지 400 bar 압력 조건 하에서 보조용매를 사용하여 초임계 이산화탄소로 초임계 추출하는 단계; 및 Supercritical extraction of the iris powder into supercritical carbon dioxide using a co-solvent under 40 ° C. to 60 ° C. temperature and 200 bar to 400 bar pressure conditions; And 상기 창포 추출물을 농축하는 단계를 포함하는 베타아사론 추출 방법.Beta asaron extraction method comprising the step of concentrating the iris extract. 제1항에 있어서, 상기 창포 분쇄물의 직경은 0.5 mm 내지 1 mm의 크기인 것을 특징으로 하는 베타아사론 추출 방법.The method of claim 1, wherein the diameter of the iris powder is beta asaron extraction method characterized in that the size of 0.5 mm to 1 mm. 제1항에 있어서, 상기 보조용매는 에탄올인 것을 특징으로 하는 베타아사론 추출 방법.The method of claim 1, wherein the co-solvent is beta asaron extraction method characterized in that the ethanol. 제4항에 있어서, 상기 보조용매는 전체 초임계 유체 혼합물 대비 1 내지 10 vol%인 것을 특징으로 하는 베타아사론 추출 방법.5. The method of claim 4, wherein the cosolvent is 1 to 10 vol% of the total supercritical fluid mixture. 제1항에 있어서, 상기 창포는 건조 창포인 것을 특징으로 하는 베타아사론 추출 방법.The method of claim 1, wherein the iris is a dry iris.
PCT/KR2013/002932 2012-04-06 2013-04-08 Method for extracting acorus calamus var. angustatus oil containing large amount of β-asarone using supercritical fluid extraction Ceased WO2013151407A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020120036330A KR101433771B1 (en) 2012-04-06 2012-04-06 A method of extracting for acorus calamus root extracts oil including β-asarone using supercritical fluid extraction
KR10-2012-0036330 2012-04-06

Publications (1)

Publication Number Publication Date
WO2013151407A1 true WO2013151407A1 (en) 2013-10-10

Family

ID=49300811

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2013/002932 Ceased WO2013151407A1 (en) 2012-04-06 2013-04-08 Method for extracting acorus calamus var. angustatus oil containing large amount of β-asarone using supercritical fluid extraction

Country Status (2)

Country Link
KR (1) KR101433771B1 (en)
WO (1) WO2013151407A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018077013A1 (en) * 2016-10-27 2018-05-03 陕西师范大学 High-efficiency supercritical oil extraction method

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101682497B1 (en) 2015-07-28 2016-12-05 주식회사 한빛향료 Method for extracting low fat seed oil
CN106854491A (en) * 2016-12-07 2017-06-16 宁夏农林科学院固原分院 A kind of selenium-rich linseed oil and preparation method thereof

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016900B1 (en) * 1994-01-03 1996-12-26 삼성전자 주식회사 Actuator retainer on hard disk drive
KR20050068283A (en) * 2003-12-30 2005-07-05 코스맥스 주식회사 A composition against skin aging comprising an acorus gramineus solander extract
KR20100038029A (en) * 2008-10-02 2010-04-12 인성실업(주) Method of producing krill oil using supercritical extraction and krill oil composition with high contents of omega-3 fatty acids

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016900A (en) * 1994-11-23 1996-06-17 Extraction of active ingredients from plants using supercritical fluid extraction

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR960016900B1 (en) * 1994-01-03 1996-12-26 삼성전자 주식회사 Actuator retainer on hard disk drive
KR20050068283A (en) * 2003-12-30 2005-07-05 코스맥스 주식회사 A composition against skin aging comprising an acorus gramineus solander extract
KR20100038029A (en) * 2008-10-02 2010-04-12 인성실업(주) Method of producing krill oil using supercritical extraction and krill oil composition with high contents of omega-3 fatty acids

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
MARONGIU, BRUNO ET AL.: "Chemical composition of the essential oil and supercritical C02 extract of Commiphora myrrha (Nees) Engl. and of Acorus calamus L..", JOURNAL OF AGRICUTURAL AND FOOD CHEMISTRY., vol. 53, 2005 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018077013A1 (en) * 2016-10-27 2018-05-03 陕西师范大学 High-efficiency supercritical oil extraction method
US10829715B2 (en) 2016-10-27 2020-11-10 Shaanxi Normal University High-efficiency supercritical oil extraction method

Also Published As

Publication number Publication date
KR20130113820A (en) 2013-10-16
KR101433771B1 (en) 2014-08-27

Similar Documents

Publication Publication Date Title
Lin et al. Antioxidant, antioedema and analgesic activities of Andrographis paniculata extracts and their active constituent andrographolide
KR100879032B1 (en) Antibacterial, antioxidant and anti-inflammatory agents with natural antibacterial and anti-inflammatory effects and cosmetic compositions containing the same
Khalili et al. Antihypoxic activities of Eryngium caucasicum
Verma et al. A potential antimicrobial agent from Cocos nucifera mesocarp extract; Development of a new generation antibiotic
JP2009132662A (en) Glutathione production promoter
KR101571323B1 (en) Cosmetic compositions comprising extract of herbs
WO2013151407A1 (en) Method for extracting acorus calamus var. angustatus oil containing large amount of β-asarone using supercritical fluid extraction
CN104523479B (en) Application and whitening articles for use of the himalayan prinsepia leaf extract in whitening articles for use
KR101990387B1 (en) Oriental cosmetic composition comprising the extract of coptis chinensis
CN104473825A (en) Longan seed polyphenol extraction and purification method and application of longan seed polyphenol in preparing polyphenol whitening cosmetics
CN101137389B (en) Pulsatilla spp. extracts effective in brain function
KR101202393B1 (en) Herb extracts using living organic herbs, treatment composition for atopic dermatitis, and method of manufacturing thereof
KR20170044455A (en) External preparation for skin comprising extract of Traditional herb
KR100670238B1 (en) Cosmetic composition for improving skin wrinkles containing herbal extract and method for producing same
Bouftira et al. Antioxidant properties of Mesembryanthemum crystallinum and Carpobrotus edulis extracts.
WO2010058984A2 (en) Antioxidant composition containing extract of processed chrysanthemum indicum or citrus unshiu peel
Chaudhuri et al. Phytochemical composition of the extracts from Iresine herbstii and its therapeutic use via antioxidant and cytotoxic potential by multiple in vitro assays
JP2020164481A (en) Prostaglandin E2 production inhibitor
KR100624664B1 (en) Hair cosmetic composition for dandruff growth inhibition and scalp itch improvement
CN113402573B (en) A kind of tannin compound and its extraction method and application
KR102215827B1 (en) Natural herbal composition for acne improvement and a method of manufacturing the same
Kaur et al. Peppermint essential oil
CN108272705A (en) A kind of anti-inflammatory and antalgic maintenance composition
KR20190025104A (en) Natural feed additive composition and its preventive and therapeutic effect on Myxozoa
CN120549825A (en) Water lily skin care extract and its preparation method and application

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 13772758

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 13772758

Country of ref document: EP

Kind code of ref document: A1